Improving Executive Functions After Traumatic Brain Injury (TBI): A Clinical Trial of the "Executive Plus" Program
2 other identifiers
interventional
77
1 country
1
Brief Summary
This is a randomized clinical trial which compares a standard day treatment program for individuals with TBI with the "Executive Plus" program; the latter emphasizes training of attention, emotional self-regulation and problem solving. The goal of the Executive Plus program is to maximize executive functioning, as well as the long-term outcomes of community participation and satisfaction with daily life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2005
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2005
CompletedFirst Submitted
Initial submission to the registry
October 3, 2005
CompletedFirst Posted
Study publicly available on registry
October 5, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2010
CompletedSeptember 24, 2013
September 1, 2013
5.1 years
October 3, 2005
September 23, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (5)
Cognitive function
At baseline
Cognitive function
5 weeks into treatment
Cognitive function
At treatment end (6 months after baseline)
Cognitive function
6 months after completing treatment
Cognitive function
12 months after completing treatment
Secondary Outcomes (25)
Memory
At baseline
Memory
5 weeks into treatment
Memory
At treatment end (6 months after baseline)
Memory
6 months after completing treatment
Memory
12 months after completing treatment
- +20 more secondary outcomes
Study Arms (2)
Standard Treatment
ACTIVE COMPARATORcognitive rehabilitation day treatment program
Top-Down
EXPERIMENTALcognitive rehabilitation day treatment program that incorporates systematic "top down" treatment of executive function deficits (problem solving and emotional regulation training), systematic treatment of attention deficits, and modular, contextual and embedded approaches to treatment.
Interventions
Eligibility Criteria
You may qualify if:
- At least 18 years old
- Having a TBI as a result of a blow to the head followed by a loss of consciousness or period of being dazed and confused or a period of post traumatic amnesia or clinical signs of altered neurological function; this information must be medically documented (e.g., emergency medical record, hospital record, neuroradiological report, or neurological exam or record of physician's visit within 24 hours of injury).
- At least three months post-injury
- English-speaking (treatment sessions will be conducted in English)
- Reporting executive dysfunction (by self or family)
- Willing and able to participate in and travel to the program daily for six months
- Oriented to time, place and person
- Having a full-scale intelligence quotient (IQ) of at least 75
- Having a score on the Galveston Orientation and Amnesia Test of 75 or more
- Having communication skills adequate to participate in groups
- Having at least a sixth-grade reading level (for testing and use of written materials)
- Willing to complete questionnaires and interviews about mood, thinking skills, participation and the like
- Agree to participate, i.e., completion of informed consent and Health Insurance Portability and Accountability Act (HIPAA) documents
You may not qualify if:
- Active substance abuse
- Active psychosis
- Active suicidality
- Disruptive or violent behavior to self or others
- Current cognitive rehabilitation (this does not include psychotherapy)
- No impairment on the Frontal Systems Behavior Scale (FRSBE) or Wisconsin Card Sorting Test (WCST)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Icahn School of Medicine at Mount Sinai
New York, New York, 10029-6574, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Wayne A Gordon, Ph.D.
Icahn School of Medicine at Mount Sinai
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 3, 2005
First Posted
October 5, 2005
Study Start
October 1, 2005
Primary Completion
November 1, 2010
Study Completion
November 1, 2010
Last Updated
September 24, 2013
Record last verified: 2013-09